Research statistics

Pralmorelin (GHRP-2) research: publications and trials

What has been published on Pralmorelin (GHRP-2): PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Pralmorelin (GHRP-2) works or is safe. For what it is and what the studies found, see the Pralmorelin (GHRP-2) profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

202

Since 1993

Publications in 2026 so far

4

Through November 15, 2026

Human clinical research

45.0%

91 of 202 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

44

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

47.0%

68 animal · 27 in vitro · 0 computational

Records that only mention it

36

Not counted above

Status in the library: Research only. Groups: Growth hormone axis.

Publications by year

Pralmorelin (GHRP-2) publications by year and evidence

1993, Reviews and meta-analyses: 1 of 11994, Preclinical (animal, in vitro, computational): 2 of 21995, Human clinical research: 3 of 61995, Preclinical (animal, in vitro, computational): 3 of 61996, Human clinical research: 2 of 91996, Preclinical (animal, in vitro, computational): 6 of 91996, Reviews and meta-analyses: 1 of 91997, Human clinical research: 5 of 111997, Preclinical (animal, in vitro, computational): 5 of 111997, Reviews and meta-analyses: 1 of 111998, Human clinical research: 6 of 181998, Preclinical (animal, in vitro, computational): 9 of 181998, Reviews and meta-analyses: 3 of 181999, Human clinical research: 5 of 71999, Preclinical (animal, in vitro, computational): 2 of 72000, Human clinical research: 6 of 122000, Preclinical (animal, in vitro, computational): 5 of 122000, Reviews and meta-analyses: 1 of 122001, Human clinical research: 4 of 92001, Preclinical (animal, in vitro, computational): 4 of 92001, Reviews and meta-analyses: 1 of 92002, Human clinical research: 2 of 92002, Preclinical (animal, in vitro, computational): 7 of 92003, Human clinical research: 1 of 32003, Preclinical (animal, in vitro, computational): 2 of 32004, Human clinical research: 6 of 132004, Preclinical (animal, in vitro, computational): 6 of 132004, Reviews and meta-analyses: 1 of 132005, Human clinical research: 4 of 112005, Preclinical (animal, in vitro, computational): 7 of 112006, Human clinical research: 1 of 32006, Preclinical (animal, in vitro, computational): 2 of 32007, Human clinical research: 5 of 72007, Preclinical (animal, in vitro, computational): 2 of 72008, Human clinical research: 3 of 42008, Reviews and meta-analyses: 1 of 42009, Human clinical research: 8 of 142009, Preclinical (animal, in vitro, computational): 6 of 142010, Human clinical research: 7 of 102010, Preclinical (animal, in vitro, computational): 2 of 102010, Reviews and meta-analyses: 1 of 102011, Human clinical research: 3 of 82011, Preclinical (animal, in vitro, computational): 4 of 82011, Reviews and meta-analyses: 1 of 82012, Human clinical research: 1 of 42012, Preclinical (animal, in vitro, computational): 3 of 42013, Human clinical research: 2 of 42013, Preclinical (animal, in vitro, computational): 2 of 42014, Human clinical research: 1 of 62014, Preclinical (animal, in vitro, computational): 4 of 62014, Other and not yet classified: 1 of 62015, Human clinical research: 2 of 52015, Preclinical (animal, in vitro, computational): 3 of 52016, Human clinical research: 2 of 42016, Preclinical (animal, in vitro, computational): 2 of 42017, Human clinical research: 2 of 22018, Human clinical research: 3 of 62018, Preclinical (animal, in vitro, computational): 2 of 62018, Other and not yet classified: 1 of 62019, Human clinical research: 1 of 22019, Preclinical (animal, in vitro, computational): 1 of 22020, Preclinical (animal, in vitro, computational): 2 of 32020, Reviews and meta-analyses: 1 of 32022, Human clinical research: 2 of 22023, Human clinical research: 1 of 12024, Human clinical research: 1 of 22024, Preclinical (animal, in vitro, computational): 1 of 22026 (to date), Human clinical research: 2 of 42026 (to date), Preclinical (animal, in vitro, computational): 1 of 42026 (to date), Reviews and meta-analyses: 1 of 4Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0510152019932000200720142026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
199300101
199402002
199533006
199626109
1997551011
1998693018
199952007
2000651012
200144109
200227009
200312003
2004661013
2005470011
200612003
200752007
200830104
2009860014
2010721010
201134108
201213004
201322004
201414016
201523005
201622004
201720002
201832016
201911002
202002103
202220002
202310001
202411002
2026 (to date)21104

Study types

Animal study68
Randomized controlled trial44
Other clinical trial30
In vitro study27
Review14
Observational human study13
Case report4
Editorial, letter or other2

Research areas

From MeSH major topics. A paper can be in several areas.

Endocrinology133
Neurological and mental health53
Metabolic health32
Longevity and aging24
Obesity and weight management24
Musculoskeletal12
Reproductive and sexual health11
Oncology10
Cardiovascular8
Tissue repair8
Gastrointestinal6
Immune system6

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.

    PloS one · February 19, 2016 · Randomized controlled trial · cited 29 times · open access

    PMID 26894743 · DOI 10.1371/journal.pone.0149461 · Human clinical research

  2. Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · October 1, 2014 · Randomized controlled trial · cited 5 times · open access

    PMID 25374440 · DOI 10.1297/cpe.23.107 · Human clinical research

  3. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.

    European journal of endocrinology · November 29, 2013 · Randomized controlled trial · cited 15 times · open access

    PMID 24114435 · DOI 10.1530/eje-13-0733 · Human clinical research

  4. Differential pulsatile secretagogue control of GH secretion in healthy men.

    American journal of physiology. Regulatory, integrative and comparative physiology · March 13, 2013 · Randomized controlled trial · cited 5 times · open access

    PMID 23485864 · DOI 10.1152/ajpregu.00069.2013 · Human clinical research

  5. Regulated recovery of pulsatile growth hormone secretion from negative feedback: a preclinical investigation.

    American journal of physiology. Regulatory, integrative and comparative physiology · July 27, 2011 · Randomized controlled trial · cited 4 times · open access

    PMID 21795635 · DOI 10.1152/ajpregu.00293.2011 · Human clinical research

  6. Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.

    The Journal of clinical endocrinology and metabolism · May 25, 2011 · Randomized controlled trial · cited 11 times · open access

    PMID 21613353 · DOI 10.1210/jc.2011-0298 · Human clinical research

  7. Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.

    American journal of physiology. Endocrinology and metabolism · April 5, 2011 · Randomized controlled trial · cited 8 times · open access

    PMID 21467302 · DOI 10.1152/ajpendo.00054.2011 · Human clinical research

  8. Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.

    European journal of endocrinology · March 18, 2010 · Randomized controlled trial · cited 2 times · open access

    PMID 20299490 · DOI 10.1530/eje-10-0149 · Human clinical research

  9. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.

    The Journal of clinical endocrinology and metabolism · October 26, 2009 · Randomized controlled trial · cited 18 times · open access

    PMID 19858315 · DOI 10.1210/jc.2009-1769 · Human clinical research

  10. Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.

    American journal of physiology. Endocrinology and metabolism · May 26, 2009 · Randomized controlled trial · cited 18 times · open access

    PMID 19470834 · DOI 10.1152/ajpendo.00230.2009 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.

    The Journal of clinical endocrinology and metabolism · April 1, 1999 · Randomized controlled trial · cited 233 times

    PMID 10199772 · DOI 10.1210/jcem.84.4.5636 · Human clinical research

  2. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.

    The Journal of clinical endocrinology and metabolism · February 1, 1998 · Randomized controlled trial · cited 204 times

    PMID 9467533 · DOI 10.1210/jcem.83.2.4575 · Human clinical research

  3. GH releasing peptides--structure and kinetics.

    The Journal of pediatric endocrinology · January 1, 1993 · Review · cited 181 times

    PMID 8374685 · DOI 10.1515/jpem.1993.6.1.21 · Reviews and meta-analyses

  4. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.

    American journal of physiology. Endocrinology and metabolism · October 26, 2004 · Animal study · cited 172 times · open access

    PMID 15507538 · DOI 10.1152/ajpendo.00196.2004 · Animal studies

  5. Growth hormone-releasing peptides.

    European journal of endocrinology · May 1, 1997 · Review · cited 168 times

    PMID 9186261 · DOI 10.1530/eje.0.1360445 · Reviews and meta-analyses

Latest publications

  1. Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests.

    Endocrine journal · September 11, 2026 · Observational human study · cited 0 times · open access

    PMID 42732957 · DOI 10.1507/endocrj.ej26-0192 · Human clinical research

  2. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

    Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access

    PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses

  3. Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone.

    International journal of molecular sciences · January 14, 2026 · Observational human study · cited 1 times · open access

    PMID 41596479 · DOI 10.3390/ijms27020832 · Human clinical research

  4. Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys.

    In vivo (Athens, Greece) · January 1, 2026 · Animal study · cited 0 times · open access

    PMID 41482410 · DOI 10.21873/invivo.14182 · Animal studies

  5. Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.

    Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · December 12, 2024 · Animal study · cited 8 times

    PMID 39672241 · DOI 10.1016/j.arthro.2024.11.094 · Animal studies

  6. Robust growth hormone responses to GH-releasing peptide 2 in adolescents.

    Journal of pediatric endocrinology & metabolism : JPEM · July 4, 2024 · Observational human study · cited 0 times

    PMID 38958228 · DOI 10.1515/jpem-2024-0115 · Human clinical research

  7. Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · June 2, 2023 · Observational human study · cited 0 times · open access

    PMID 37295337 · DOI 10.1016/j.ghir.2023.101545 · Human clinical research

  8. Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

    Journal of the Endocrine Society · June 6, 2022 · Other clinical trial · cited 7 times · open access

    PMID 35795807 · DOI 10.1210/jendso/bvac088 · Human clinical research

  9. Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.

    PloS one · April 22, 2022 · Observational human study · cited 3 times · open access

    PMID 35452483 · DOI 10.1371/journal.pone.0267324 · Human clinical research

  10. On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.

    Drug testing and analysis · November 25, 2020 · In vitro study · cited 16 times

    PMID 33197153 · DOI 10.1002/dta.2975 · In vitro studies

Browse all 202 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: GHRP-2; GPA 748; KP-102; Pralmorelin

((TITLE_ABS:"GHRP-2" OR CHEM:"GHRP-2" OR TITLE_ABS:"GHRP2" OR CHEM:"GHRP2") OR (TITLE_ABS:"GPA 748" OR CHEM:"GPA 748" OR TITLE_ABS:"GPA748" OR CHEM:"GPA748") OR (TITLE_ABS:"KP-102" OR CHEM:"KP-102" OR TITLE_ABS:"KP102" OR CHEM:"KP102") OR (TITLE_ABS:"Pralmorelin" OR CHEM:"Pralmorelin")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Pralmorelin (GHRP-2) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/pralmorelin-ghrp2